Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Discrimination between rival dosing histories

E N Jonsson1, J R Wade, G Almqvist

  • 1Dept of Pharmacy, Uppsala University, Sweden. niclas.jonsson@biof.uu.se

Pharmaceutical Research
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Handling underlying discrete variables with bivariate mixed hidden Markov models in NONMEM.

Journal of pharmacokinetics and pharmacodynamics·2019
Same author

CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

Clinical pharmacology and therapeutics·2018
Same author

Reduced and optimized trial designs for drugs described by a target mediated drug disposition model.

Journal of pharmacokinetics and pharmacodynamics·2018
Same author

Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials.

Journal of clinical pharmacology·2018
Same author

Model averaging for robust assessment of QT prolongation by concentration-response analysis.

Statistics in medicine·2017
Same journal

Leveraging Carnitine-functionalized Lipid Nanocarrier based Targeted Delivery of A1874 PROTAC for Glioblastoma.

Pharmaceutical research·2026
Same journal

Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

Pharmaceutical research·2026
Same journal

Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis.

Pharmaceutical research·2026
Same journal

Spray Dried Lysozyme Microspheres: Morphological Evolution and Enzymatic Activity Retention.

Pharmaceutical research·2026
Same journal

Colloidal Stability of Amorphous Nanoparticles in Solution: Impact of Stabilizer.

Pharmaceutical research·2026
Same journal

Impact of Mixing Approach and Bubble Formation on In Situ Forming Implant Properties.

Pharmaceutical research·2026
See all related articles

This study introduces a robust procedure to select the most plausible dosing history in population pharmacokinetic analyses. This method improves parameter estimation and aids in comparing dosage recording techniques.

Area of Science:

  • Pharmacokinetics
  • Pharmacometrics
  • Drug Development

Background:

  • Dosing history accuracy is crucial for population pharmacokinetic (PopPK) models.
  • Inconsistent or multiple dosing records (e.g., patient diaries, electronic monitoring devices) pose challenges.
  • Objective methods are needed to reconcile conflicting dosing information.

Purpose of the Study:

  • To develop and validate a procedure for selecting the most plausible dosing history from multiple sources in PopPK studies.
  • To enhance the reliability of PopPK model parameter estimation.
  • To provide an objective basis for comparing different patient dosing recording methodologies.

Main Methods:

  • A four-step procedure involving consistency checks, model building with consistent data, selection of histories for remaining individuals, and model refinement.

Related Experiment Videos

  • Evaluation using both simulated data and a real-world dataset comparing patient diaries and MEMS (Medication Event Monitoring System) data.
  • Development of a population pharmacokinetic model to aid in the selection process.

    • Main Results:

    • The developed procedure significantly improved parameter estimation accuracy compared to using single or unselected dosing histories.
    • In a real dataset, the procedure led to lower variability estimates and favored diary-based dosing histories over MEMS.
    • Simulations confirmed that the selection procedure yielded parameter estimates closer to true values.

    Conclusions:

    • The proposed procedure is robust and enhances parameter estimation for population pharmacokinetic and PK/PD models.
    • It offers objective insights for comparing dosage recording methods and assessing patient adherence behavior.
    • This methodology is valuable for improving the quality and interpretability of PopPK studies.